The Investigation of Latanoprost's Effects on the Intraocular Pressure of Healthy Male guinea Pigs Under Light and Dark Regimes. [PDF]
Vet Med SciArmin A, Arfaee F.
europepmc +1 more source
Clinical Benefits of Preservative-Free Treatment for Glaucoma with a Focus on Preservative-Free Latanoprost. [PDF]
Ophthalmol TherDhaliwal DK +4 more
europepmc +1 more source
Severe Permanent Visual Decline After Hypotony-Induced Retinal Pigment Epithelial Changes. [PDF]
CureusBenekos K +4 more
europepmc +1 more source
Using selective laser trabeculoplasty to manage glaucoma in a child with phakomatosis pigmentovascularis. [PDF]
Am J Ophthalmol Case RepBai P +4 more
europepmc +1 more source
Quantifying latanoprost-induced conjunctival hyperemia by anterior segment optical coherence tomography angiography. [PDF]
Int J OphthalmolVahedian Z +3 more
europepmc +1 more source
Very High Molecular Weight Hyaluronic Acid as an Enhanced Vehicle in Therapeutic Eye Drops: Application in a Novel Latanoprost Formulation for Glaucoma. [PDF]
Bioengineering (Basel)Pujol-Martí J, Müller-Lierheim WGK.
europepmc +1 more source
Magistral Galenic Preparations in Modern Dermatology: Our Top 10 Picks for Bridging Therapeutic Gaps. [PDF]
Medicina (Kaunas)Cammarata E +4 more
europepmc +1 more source
The Effect of Preoperative Use of High- vs. Low-PAP-Inducing-Potential FP Agonists on the Surgical Outcomes of Trabeculectomy and AGV Implantation. [PDF]
J Clin MedYamazaki I +9 more
europepmc +1 more source
Maximum Tolerated Medical Therapy for Glaucoma: Fixed-Dose Combinations of Timolol, Dorzolamide, Brimonidine with Latanoprost Versus Timolol, Dorzolamide with Latanoprost. [PDF]
Clin OphthalmolOlvera-Montaño O +4 more
europepmc +1 more source
A Study of 24-h Efficacy and Safety of Sepetaprost vs. Latanoprost in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension. [PDF]
Adv TherKonstas AG +4 more
europepmc +1 more source